Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

NCT05832086 is registered in ClinicalTrials.gov with Stephen Freedland as lead sponsor.

NCT NCT05832086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05832086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Lead sponsor
Stephen Freedland
Phase
Phase 2
Overall status
Recruiting
Start date
September 13, 2023
Completion date
March 30, 2029
Enrollment
138 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma